Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19; Immunity”

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT06070961
What this trial is testing

Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance

Who this might be right for
Follicular Lymphoma
Fondazione Italiana Linfomi - ETS 56
Not applicableStudy completedNCT04510012
What this trial is testing

Characterizing the Immune Response and Neuronal Damage in COVID-19

Who this might be right for
SARS-CoV InfectionCovid-19
Insel Gruppe AG, University Hospital Bern 88
Not applicableStudy completedNCT05951920
What this trial is testing

Lymph Node Aspiration to Decipher the Immune Response of Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated With at Least 3 Doses of COVID-19 mRNA Vaccine.

Who this might be right for
COVID-19
Assistance Publique - Hôpitaux de Paris 12
Post-approval studies (Phase 4)Study completedNCT05778383
What this trial is testing

Zinc Supplementation Impact in Acute COVID-19 Clinical Outcomes

Who this might be right for
Zinc DeficiencySars-CoV-2 Infection
Parc de Salut Mar 75
Not applicableStudy completedNCT04888793
What this trial is testing

Immune Response to Anti COVID-19 Vaccine in Immunocompromised Patients: a Cohort Study

Who this might be right for
Covid19COVID-19 Vaccines
Pontificia Universidad Catolica de Chile 260
Testing effectiveness (Phase 2)Ended earlyNCT04276896
What this trial is testing

Immunity and Safety of Covid-19 Synthetic Minigene Vaccine

Who this might be right for
Pathogen Infection Covid-19 Infection
Shenzhen Geno-Immune Medical Institute 100
Not applicableStudy completedNCT04562285
What this trial is testing

Sustained Immunity to COVID-19 as Measured by SARS-CoV-2 Serology Assays

Who this might be right for
Covid19
Henry Ford Health System 829
Not applicableLooking for participantsNCT05458440
What this trial is testing

Bank of Human Leukocytes From COVID-19 Convalescent Donors With an Anti-SARS-CoV-2 Cellular Immunity

Who this might be right for
COVID-19
Central Hospital, Nancy, France 32
Not applicableLooking for participantsNCT05858502
What this trial is testing

Understanding the Determinants of Mucosal Immunity and Optimizing the Diagnosis of Infection With SARS-CoV-2 Variants

Who this might be right for
COVID-19
Institut Pasteur 90
Testing effectiveness (Phase 2)UnknownNCT04748471
What this trial is testing

Immunogenecity and Safety of VaccinemRNA-1273 in Elderly Volunteers (Over 65 y) Compared to Younger Ones (18-45y)

Who this might be right for
Prevention of COVID19
Assistance Publique - Hôpitaux de Paris 180
Large-scale testing (Phase 3)UnknownNCT05059106
What this trial is testing

EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19

Who this might be right for
SARS-CoV-2
Federal University of Espirito Santo 29,637
Not applicableEnded earlyNCT05124574
What this trial is testing

Transplacental Transmission of COVID-19

Who this might be right for
SARS-COV-2 Infection
Centre Hospitalier Universitaire de Saint Etienne 10
Early research (Phase 1)Looking for participantsNCT07464314
What this trial is testing

A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

Who this might be right for
Influenza, Human+COVID-19
GlaxoSmithKline 225
Not applicableStudy completedNCT04494893
What this trial is testing

ImmuneRACE - Immune Response Action to COVID-19 Events

Who this might be right for
Covid19
Adaptive Biotechnologies 808
Not applicableStudy completedNCT04424004
What this trial is testing

MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study

Who this might be right for
COVID 19
Duke University 300
Early research (Phase 1)Study completedNCT05972993
What this trial is testing

A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Healthy Adults

Who this might be right for
COVID-19
GlaxoSmithKline 114
Not applicableStudy completedNCT04431414
What this trial is testing

Immune Responses to the Virus That Causes COVID-19

Who this might be right for
SARS-CoV-2COVID-19
COVID-19 Prevention Network 953
Not applicableStudy completedNCT04355338
What this trial is testing

Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil (AVISA)

Who this might be right for
COVID-19
Butantan Institute 3,520
Not applicableStudy completedNCT04418206
What this trial is testing

Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19

Who this might be right for
Covid 19
Centre Hospitalier Universitaire de Nice 950
Testing effectiveness (Phase 2)Study completedNCT07408297
What this trial is testing

Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed Boosters in Adolescents and Adults Aged 12-64 With and Without HIV in Kenya, DRC, and Rwanda

Who this might be right for
COVID -19SARS CoV 2 Infection
Victoria Biomedical Research Institute 1,919
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation